Document:

exv10w1

 

EXHIBIT 10.1

REGISTRATION RIGHTS AGREEMENT

     This Registration Rights Agreement (this “Agreement”) is being entered into
as of September 11, 2005, by and among eBay Inc., a Delaware corporation (the
“Purchaser”), and the persons listed on Schedule 1 hereto (the “Investors”). The
Investors and the Purchaser are sometimes referred to in this Agreement individually as a
“Party” and collectively as the “Parties.” Certain capitalized terms used in this
Agreement are defined in Exhibit A.

Recitals

     Whereas, pursuant to that certain Sale and Purchase Agreement of even date (the
“Purchase Agreement”), among the Purchaser, Skype Technologies S.A. and the Investors, the
Purchaser is issuing shares of its common stock to the Investors; and

     Whereas, in connection with the transactions contemplated by the Purchase Agreement,
the Purchaser has agreed to register, under the Securities Act, the resale of the Registrable
Shares and to grant certain other rights to the Investors.

Agreement

     The Parties, intending to be legally bound, agree as follows:

     1. Registration of the Registrable Shares; Compliance With the Securities
Act.

          1.1. Registration Procedures. The Purchaser shall:

               (a) prepare and file with the SEC, on or prior to the later of December 15, 2005 or the date
on which any historical and pro forma financial statements required to be filed by the Purchaser
with the SEC in connection with the transactions contemplated by the Purchase Agreement have been
filed with the SEC (but in no event later than 75 days following Completion, as defined in the
Purchase Agreement), a shelf registration statement (the “Registration Statement”) on Form
S-3 or other available forms to enable the resale of the Registrable Shares by the Investors from
time to time on a delayed or continuous basis pursuant to Rule 415 under the Securities Act through
the automated quotation system of the Nasdaq National Market or such other market as may be the
principal market on which the Purchaser Common Stock is quoted or listed, or in any other manner
reasonably requested by the Investors;

               (b) use all reasonable efforts to cause the Registration Statement to become effective as soon
as practicable after the Registration Statement is filed by the Purchaser;

               (c) to the extent applicable, use all reasonable efforts to prepare and file with the SEC such
amendments and supplements to the Registration Statement and the prospectus forming part thereof
(the “Prospectus”) as may be necessary to keep the Registration Statement current and
effective until the earlier of: (i) two years following the date on which the Registration
Statement first becomes effective; or (ii) the date on which all of the Registrable Shares may be
sold pursuant to Rule 144 under the Securities Act (“Rule 144”) without regard to any
volume limitations;

               (d) take such reasonable action as may be necessary so that: (i) the Registration Statement
and the Prospectus and any amendments or supplements thereto (and each report or other

1

 

document incorporated therein by reference) comply in all material respects with the
Securities Act and the Exchange Act; (ii) the Registration Statement and any amendment thereto do
not, when they become effective, contain an untrue statement (as defined below) of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading; and (iii) the Prospectus, and any amendment or supplement to the
Prospectus, does not, as of its date, include an untrue statement (as defined below) of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading;

               (e) furnish to the Investors such number of copies of the Registration Statement, the
Prospectus, preliminary prospectuses, prospectus supplements or periodic or current reports
incorporated into such Registration Statement identifying the Investors as selling stockholders (an
“Identifying Report”), as applicable in conformity with the requirements of the Securities
Act and such other documents as the Investors may reasonably request, in order to facilitate the
public sale or other disposition of all or any of the Registrable Shares by the Investors;

               (f) take all reasonable actions necessary to ensure that the Registrable Shares are listed and
available for quotation on The Nasdaq National Market or such other market as may be the principal
market on which the Purchaser Common Stock is quoted or listed;

               (g) to the extent necessary to properly sell any Registrable Shares under the Registration
Statement, deliver to each Investor, without charge, as many copies of the Prospectus (including
each prospectus subject to completion) and any amendments or supplements thereto as such Investor
may reasonably request in order to permit the offering and sale of the Registrable Shares, but only
while the Purchaser shall be required under the provisions hereof to cause the Registration
Statement to remain effective, and the Purchaser consents (except during a suspension period
permitted by this Agreement) to the use of the Prospectus or any amendment or supplement thereto by
the Investor in connection with the offering and sale of the Registrable Shares covered by the
Prospectus or any amendment or supplement thereto in accordance with the terms hereof;

               (h) prior to any offering of Registrable Shares pursuant to the Registration Statement, use
all reasonable efforts to register or qualify or cooperate with the Investors and their respective
counsel in connection with the registration or qualification of such Registrable Shares for offer
and sale under the securities or blue sky laws of such jurisdictions in the United States as any
Investor reasonably requests in writing and to keep such registration or qualification (or
exemption therefrom) effective during the period such Registration Statement is required to be kept
effective and to do all other acts or things reasonably necessary or advisable to enable the
disposition in such distributions of the securities covered by the Registration Statement;
provided, however, that the Purchaser will not be required to: (i) qualify to do business in any
jurisdiction where it would not otherwise be required to qualify, but for this paragraph (h); (ii)
subject itself to general taxation in any such jurisdiction; or (iii) file a general consent to
service of process in any such jurisdiction;

               (i) comply with all applicable rules and regulations of the SEC relating to such registration
and the distribution of the securities being offered pursuant to the Registration Statement and, to
the extent applicable, make generally available to its securities holders, as soon as reasonably
practicable, earnings statements satisfying the provisions of Section 11(a) of the Securities Act;

               (j) use all reasonable efforts to cause all Registrable Shares covered by the Registration
Statement to be registered with or approved by such Governmental Entities as may be

2

 

necessary in the written opinion of counsel to the Purchaser and counsel to an Investor to
enable the Investor to consummate the disposition of such Registrable Shares;

               (k) cooperate with each Investor to facilitate the timely preparation and delivery of
certificates representing Registrable Shares sold pursuant to the Registration Statement, and
provide the transfer agent with certificates for such Registrable Shares that are in a form that
does not contain any restrictive legend;

               (l) notify the Investors promptly after it shall receive notice or obtain knowledge of the
issuance of any stop order by the SEC delaying or suspending the effectiveness of the Registration
Statement or of the initiation or threat of any proceeding for that purpose and promptly use all
reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such
stop order should be issued; and

               (m) bear all expenses (exclusive of underwriting discounts and commissions and fees and
expenses of counsel to any Investor) in connection with the procedures in paragraph (a) through (l)
of this Section 1.1 and the registration of the Registrable Shares pursuant to the Registration
Statement; and

               (n) use all reasonable efforts to take all other reasonable steps necessary to effect the
resale of the Registrable Shares.

          1.2. Investor Obligations.

               (a) In connection with the Registration Statement referred to in Section 1.1, each Investor
shall: (i) furnish such information as the Purchaser may reasonably request in connection with the
preparation of the Registration Statement and the Prospectus, any prospectus supplement or
Identifying Report in order to permit the Purchaser to comply with all applicable securities laws
and requirements of the SEC; and (ii) complete, execute, acknowledge and/or deliver such
questionnaires and other documents, certificates and instruments as are reasonably required by the
Purchaser in connection with any offering under this Agreement.

               (b) Each Investor shall promptly notify the Purchaser of any changes known to such Investor in
the information set forth in the Registration Statement and the Prospectus, any prospectus
supplement or Identifying Report regarding such Investor or its plan of distribution. No Investor
shall use, distribute or otherwise disseminate any free writing prospectus, as defined in Rule 405
under the Securities Act, in connection with the sale of Registrable Shares under the Registration
Statement, without the prior written consent of the Purchaser.

               (c) Upon receipt of any Suspension Notice (as defined below), each Investor shall immediately
discontinue disposition of the Registerable Shares pursuant to the Registration Statement covering
such shares until the Investor receives copies of the supplemented or amended prospectus
contemplated by Section 1.3(c) or until the Investor is advised in writing by the Purchaser that
the Suspension (as defined below) is no longer in effect, and, if so directed by the Purchaser,
deliver to the Purchaser all copies of the Prospectus and any prospectus supplement or Identifying
Report covering such Registerable Shares in such Investor’s possession at the time of receipt of
such notice.

3

 

          1.3. Amendments to Registration Statement; Suspension; Sales of Registrable Shares under the
Registration Statement.

               (a) Except in the event that Section 1.3(b) or 1.3(c) applies, the Purchaser shall: (i) if
required under applicable law, prepare and file from time to time with the SEC a post-effective
amendment to the Registration Statement or a supplement or amendment to the Prospectus or any
prospectus supplement or a supplement or amendment to any document incorporated therein by
reference or file any other required report or document so that neither such Registration Statement
nor prospectus, as amended or supplemented, will contain an untrue statement (as defined below) of
a material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading;
(ii) provide the Investors with copies of any documents filed pursuant to this Section 1.3(a); and
(iii) inform the Investors that the Purchaser has complied with its obligations in this Section
1.3(a) (or that, if the Purchaser has filed a post-effective amendment to the Registration
Statement which has not yet become or been declared effective, the Purchaser will notify the
Investors to that effect, will use all reasonable efforts to secure the effectiveness of such
post-effective amendment as promptly as practicable and will promptly notify the Investors pursuant
to this Section 1.3(a) when the amendment has become effective).

               (b) The Purchaser shall not be obligated to effect a registration pursuant to Section 1.1, or
to file any amendment to the Registration Statement (or any report incorporated therein) or any or
supplement or amendment to the Prospectus or any prospectus supplement, and may suspend the
Investors’ rights to make sales pursuant to an effective registration pursuant to Section 1.1, at
any time when the Purchaser, in the good faith judgment of its Board of Directors, reasonably
believes that the filing thereof, or the offering of securities pursuant thereto, would: (i)
materially and adversely affect a pending or proposed acquisition, merger, recapitalization,
consolidation, reorganization or similar transaction, or negotiations, discussions or pending
proposals related thereto; or (ii) be seriously detrimental to the Purchaser and its stockholders,
in which event (under clause (i) or (ii) above) the Purchaser shall have the right to defer filing
of a registration statement and prospectus or prospectus supplement or Identifying Report (or to
suspend the Investors’ rights to make sales pursuant to an effective registration pursuant to
Section 1.1) for a period of not more than 30 days; provided, however, that the Purchaser shall not
utilize the right described in this Section 1.3(b) on more than two occasions of not more than
sixty days in any twelve month period.

               (c) In the event: (i) of any request by the SEC or any other federal or state governmental
authority during the period of effectiveness of the Registration Statement for amendments or
supplements to the Registration Statement or prospectus or for additional information; (ii) of the
issuance by the SEC or any other federal or state governmental authority of any stop order
suspending the effectiveness of the Registration Statement or the initiation of any proceedings for
that purpose; (iii) of the receipt by the Purchaser of any notification with respect to the
suspension of the qualification or exemption from qualification of any of the Registrable Shares
for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose;
(iv) of any event or circumstance which, upon the advice of Purchaser’s counsel, necessitates the
making of any changes in the Registration Statement, prospectus or any prospectus supplement, or
any document incorporated or deemed to be incorporated therein by reference, so that neither the
Registration Statement nor the Prospectus or, if applicable, prospectus supplement will contain any
untrue statement (as defined below) of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading; or (v) of any event or circumstance of the type
described in Section 1.3(b), then the Purchaser shall promptly deliver a certificate in writing to
the Investors (the “Suspension Notice”) to the effect of the foregoing and, upon receipt of
such Suspension Notice, each Investor will refrain from selling any Registrable Shares

4

 

pursuant to the Registration Statement (a “Suspension”) until such Investor’s receipt of copies of a
supplemented or amended prospectus prepared and filed by the Purchaser, or until it is advised in
writing by the Purchaser that the Suspension is no longer in effect.

               (d) Provided that a Suspension is not then in effect, each Investor may sell the Registrable
Shares under the Registration Statement as long as, to the extent required by law, it arranges for
delivery of a current prospectus and, if applicable, prospectus supplement or report, to the
transferee of such Registrable Shares.

               (e) In the event of a sale of any Registrable Shares by an Investor pursuant to the
Registration Statement, such Investor shall deliver to the Purchaser’s transfer agent, with a copy
to the Purchaser, a Certificate of Subsequent Sale substantially in the form attached hereto as
Exhibit B so that the Registrable Shares may be properly transferred. Assuming timely
delivery to the Purchaser’s transfer agent of one or more stock certificates representing the
Registrable Shares in proper form for transfer and assuming compliance by the Investor with the
terms of this Agreement, the Purchaser’s transfer agent will issue and make appropriate delivery of
one or more stock certificates in the name of the buyer so as to permit timely compliance by the
Investor with applicable settlement requirements.

          1.4. Assignment of Registration Rights. Any rights referred to in Section 1 may be assigned
(but only with all related obligations) by an Investor to an affiliate of such Investor, provided
that: (a) the Purchaser is, within a reasonable time prior to such assignment, furnished with
written notice of the name and address of such assignee and the securities with respect to which
such registration rights are being assigned; and (b) such assignee agrees in writing to be bound by
and subject to the terms and conditions of this Agreement.

          1.5. Indemnification.

               (a) For the purpose of this Section 1.5: (i) the term “Selling Stockholder” shall
include each Investor and each Person, if any, who controls such Investor within the meaning of
Section 15 of the Securities Act, including any officer, director, employee, trustee or affiliate
of such Investor; (ii) the term “Registration Statement” shall include any final
prospectus, exhibit, supplement or amendment included in or relating to the Registration Statement;
and (iii) the term “untrue statement” shall include any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement, or any omission or alleged
omission to state in the Registration Statement a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading.

               (b) The Purchaser shall indemnify and hold harmless each Selling Stockholder from and against
any losses, claims, damages, liabilities and expenses to which such Selling Stockholders may become
subject (under the Securities Act or otherwise) insofar as such losses, claims, damages,
liabilities and expenses (or actions or proceedings in respect thereof) arise out of, or are based
upon: (i) any untrue statement; (ii) any failure by the Purchaser to fulfill any undertaking
included in the Registration Statement; or (iii) any violation by the Purchaser of any law, rule or
regulation, and the Purchaser shall reimburse such Selling Stockholders for any reasonable legal or
other expenses reasonably incurred in investigating, defending or preparing to defend any such
action, proceeding or claim; provided, however, that the Purchaser shall not be liable in any such
case to the extent that such loss, claim, damage or liability arises out of, or is based upon, an
untrue statement made in reliance upon and in conformity with written information furnished to the
Purchaser by or on behalf of any Selling Stockholder specifically for use in preparation of the
Registration Statement or the failure of the Selling

5

 

Stockholder to comply with its covenants and agreements contained in this Agreement respecting
the sale of the Registrable Shares.

               (c) Each Investor shall indemnify and hold harmless the Purchaser (and each person, if any,
who controls the Purchaser within the meaning of Section 15 of the Securities Act, each officer of
the Purchaser who signs the Registration Statement and each director of the Purchaser) from and
against any losses, claims, damages, liabilities and expenses to which the Purchaser (or any such
officer, director or controlling person) may become subject (under the Securities Act or
otherwise), insofar as such losses, claims, damages, liabilities and expenses (or actions or
proceedings in respect thereof) arise out of, or are based upon: (i) any failure by such Investor
to comply with the covenants and agreements contained in this Agreement respecting the sale of the
Registrable Shares; or (ii) any untrue statement if such untrue statement was made in reliance upon
and in conformity with written information furnished by or on behalf of such Investor specifically
for use in preparation of the Registration Statement, and such Investor shall reimburse the
Purchaser (or such officer, director or controlling person), as the case may be, for any reasonable
legal or other expenses reasonably incurred in investigating, defending or preparing to defend any
such action, proceeding or claim, to the extent, but only to the extent, that such untrue statement
is contained in any written information furnished to the Purchaser by or on behalf of any Selling
Stockholder specifically for inclusion in the Registration Statement; provided, however, that such
Investor’s obligation to indemnify the Purchaser shall be limited to the net proceeds received by
such Investor from the sale of the Registrable Shares.

               (d) Promptly after receipt by any indemnified person of a notice of a claim or the beginning
of any action or proceeding in respect of which indemnity is to be sought against an indemnifying
person pursuant to this Section 1.5, such indemnified person shall notify the indemnifying person
in writing of such claim or of the commencement of such action or proceeding, but the failure to so
notify the indemnifying person will not relieve it from any liability which it may have to any
indemnified person under this Section 1.5 (except to the extent that such failure affects the
indemnifying person’s ability to defend such action or proceeding) or from any liability otherwise
than under this Section 1.5. Subject to the provisions hereinafter stated, in case any such action
or proceeding shall be brought against an indemnified person, the indemnifying person shall be
entitled to participate therein, and, to the extent that it shall elect by written notice delivered
to the indemnified person promptly after receiving the aforesaid notice from such indemnified
person, shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to
such indemnified person. After notice from the indemnifying person to such indemnified person of
its election to assume the defense thereof (but only for so long as such indemnifying person is
pursuing such defense in a reasonable manner), such indemnifying person shall not be liable to such
indemnified person for any legal expenses subsequently incurred by such indemnified person in
connection with the defense thereof; provided, however, that if there exists a conflict of interest
that would make it inappropriate, in the opinion of counsel to the indemnified person, for the same
counsel to represent both the indemnified person and such indemnifying person or any affiliate or
associate thereof, the indemnified person shall be entitled to retain its own counsel at the
expense of such indemnifying person; provided, however, that no indemnifying person shall be
responsible for the fees and expenses of more than one separate counsel (together with appropriate
local counsel) for all indemnified persons. In no event shall any indemnifying person be liable in
respect of any amounts paid in settlement of any action or proceeding unless the indemnifying
person shall have approved the terms of such settlement; provided, however, that such consent shall
not be unreasonably withheld or delayed. No indemnifying person shall, without the prior written
consent of the indemnified person, effect any settlement of any pending or threatened claim, action
or proceeding in respect of which any indemnified person is or could have been a party and
indemnification could have been sought hereunder by such indemnified person, unless such settlement

6

 

includes an unconditional release of such indemnified person from all liability on claims that
are the subject matter of such claim, action or proceeding.

               (e) If the indemnification provided for in this Section 1.5 is unavailable to or insufficient
to hold harmless an indemnified person under Sections 1.5(b) or 1.5(c) in respect of any losses,
claims, damages or liabilities (or actions or proceedings in respect thereof) referred to therein,
then each indemnifying person shall contribute to the amount paid or payable by such indemnified
person as a result of such losses, claims, damages or liabilities (or actions or proceedings in
respect thereof) in such proportion as is appropriate to reflect the relative fault of the
Purchaser on the one hand and the Investor, on the other, in connection with the statements or
omissions or other matters which resulted in such losses, claims, damages or liabilities (or
actions or proceedings in respect thereof), as well as any other relevant equitable considerations.
The relative fault shall be determined by reference to, among other things, in the case of an
untrue statement, whether the untrue statement relates to information supplied by the Purchaser on
the one hand or an Investor or other Selling Stockholder on the other and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such untrue
statement. The Purchaser and each Investor agree that it would not be just and equitable if
contribution pursuant to this Section 1.5(e) were determined by pro rata allocation (even if the
Investor and other Selling Stockholders were treated as one entity for such purpose) or by any
other method of allocation which does not take into account the equitable considerations referred
to above in this Section 1.5(e). Notwithstanding the provisions of this Section 1.5(e), no
Investor shall be required to contribute any amount in excess of the amount by which the net
proceeds received by such Investor from the sale of the Registrable Shares to which such loss,
claim, damage or liability relates exceeds the amount of any damages which such Investor has
otherwise been required to pay by reason of such untrue statement. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation.

     2. Rule 144. The Purchaser shall use all reasonable efforts to file the
reports required to be filed by it under the Securities Act and the Exchange Act and the rules and
regulations adopted by the SEC hereunder, all from time to time to enable each Investor to sell the
Registrable Shares owned by it without registration under the Securities Act pursuant to the
exemption provided by Rule 144, as such Rule may be amended from time to time (or any similar rule
or regulation hereafter adopted by the SEC).

     3. Miscellaneous

          3.1. Notices. A notice under this Agreement shall only be effective if it is in writing.
Faxes are permitted. Notices under this Agreement shall be sent to the addresses set forth below,
provided that the Purchaser may change its notice details on giving notice to the Investors (and
any Investor may change its notice details on giving notice to the Purchaser) of the change in
accordance with this clause (which notice shall only be effective on the day following five clear
Business Days after the notification has been received or such later date as may be specified in
the notice). Any notice given under this Agreement shall, in the absence of earlier receipt, be
deemed to have been duly given as follows: (a) if delivered personally, on delivery; (b) if sent by
first class post, two clear Business Days after the date of posting; and (c) if sent by facsimile,
when despatched. Any notice given under this Agreement outside Working Hours in the place to which
it is addressed shall be deemed not to have been given until the start of the next period of
Working Hours in such place.

if to the Purchaser, to the address for notices to the Purchaser under the Purchase
Agreement.

7

 

if to an Investor, to the address for notices to such Investor under the Purchase
Agreement.

          3.2. Governing Law; Venue.

               (a) This Agreement shall be construed in accordance with, and governed in all respects by, the
laws of the State of Delaware (without giving effect to principles of conflicts of law).

               (b) Any legal proceeding relating to this Agreement or the enforcement of any provision of
this Agreement shall be brought or otherwise commenced in any state or federal court located in the
County of Santa Clara, State of California. Each Party:

     (i) expressly and irrevocably consents and submits to the jurisdiction of each
state and federal court located in the County of Santa Clara, State of California
(and each appellate court located in the State of California) in connection with any
such legal proceeding;

     (ii) agrees that each state and federal court located in the County of Santa
Clara, State of California shall be deemed to be a convenient forum; and

     (iii) agrees not to assert (by way of motion, as a defense or otherwise), in
any such legal proceeding commenced in any state or federal court located in the
County of Santa Clara, State of California, any claim that such Party is not subject
personally to the jurisdiction of such court, that such legal proceeding has been
brought in an inconvenient forum, that the venue of such legal proceeding is
improper or that this Agreement or the subject matter of this Agreement may not be
enforced in or by such court.

          3.3. Successors and Assigns. Subject to Section 1.4: (a) the Purchaser may not assign any of
its rights or delegate any of its obligations under this Agreement (whether voluntarily,
involuntarily, by way of merger or otherwise) to any other Person without the prior written consent
of Investors holding at least a majority of the Registrable Shares at the time of such requested
assignment or delegation; (b) except as set forth in Section 1.4, no Investor may assign any of its
rights or delegate any of its obligations under this Agreement (whether voluntarily, involuntarily,
by way of merger or otherwise) to any other Person without the prior written consent of the
Purchaser.

          3.4. Parties in Interest. None of the provisions of this Agreement is intended to provide any
rights or remedies to any Person other than the Parties and their respective successors and assigns
(if any) and, with respect to Section 1.5, the indemnified persons described therein.

          3.5. Severability. In the event that any provision of this Agreement, or the application of
any such provision to any Person or set of circumstances, shall be determined to be invalid,
unlawful, void or unenforceable to any extent, the remainder of this Agreement, and the application
of such provision to Persons or circumstances other than those as to which it is determined to be
invalid, unlawful, void or unenforceable, shall not be impaired or otherwise affected and shall
continue to be valid and enforceable to the fullest extent permitted by law.

          3.6. Entire Agreement. This Agreement and the other agreements referred to herein constitute
the whole and only agreement among the Parties relating to the matters provided for herein. In

8

 

entering into this Agreement, the Parties acknowledge that they are not relying upon any
pre-contractual statement that is not expressly set out herein.

          3.7. Waiver. Except as otherwise expressly provided in this Agreement, no delay or omission
by any Party in exercising any right, power or remedy provided by law or under this Agreement or
any other documents referred to in it shall: (a) affect that right, power or remedy; or (b) operate
as a waiver thereof. Except as otherwise expressly provided in this Agreement, the single or
partial exercise of any right, power or remedy provided by law or under this Agreement shall not
preclude any other or further exercise of it or the exercise of any other right, power or remedy.

          3.8. Amendments. This Agreement may not be amended, modified, altered or supplemented other
than by means of a written instrument duly executed and delivered by the Purchaser and Investors
holding at least a majority of the Registrable Shares at the time of the amendment, modification,
alteration or supplement (it being understood that upon such execution and delivery, such
amendment, modification, alteration or supplement shall be binding on all Investors).

          3.9. Counterparts and Exchanges by Electronic Transmission or Facsimile. This Agreement may
be executed in several counterparts, each of which shall constitute an original and all of which,
when taken together, shall constitute one agreement. The delivery of this Agreement by facsimile
or by electronic delivery in Portable Document Format (“pdf”) format shall be sufficient to bind
each Party to the terms and conditions of this Agreement.

          3.10. Effective Date. This Agreement shall become effective upon the consummation of the
share purchase contemplated by the Purchase Agreement (it being understood that if the Purchase
Agreement is terminated, this Agreement shall have no further force or effect).

          3.11. Construction.

               (a) For purposes of this Agreement, whenever the context requires: the singular number shall
include the plural, and vice versa; the masculine gender shall include the feminine and neuter
genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender
shall include the masculine and feminine genders.

               (b) As used in this Agreement, the words “include” and “including,” and variations thereof,
shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the
words “without limitation.”

               (c) Unless the context otherwise requires, references in this Agreement to “Sections,”
“Schedules” and “Exhibits” are intended to refer to Sections of and Schedules and Exhibits to this
Agreement.

               (d) The bold-faced headings of the various sections of this Agreement have been inserted for
convenience of reference only and shall not be deemed to be part of this Agreement.

[Signatures on next page]

9

 

     In Witness Whereof, the Parties have caused this Agreement to be executed and
delivered as of September 11, 2005.

	 	 	 	 	 
	 	eBay Inc.,

    a Delaware corporation

 	 
	 	By:  	/s/ Margaret C. Whitman	 
	 	 	 	 
	 	 	 	 
	 

Signature Page to Registration Rights Agreement

 

 

     The Parties have caused this Agreement to be executed as of September 11, 2005.

	 	 	 
	 

	 	Investors
	 
	 	 
	 

	 	/s/ [Investor signatures]
                         
                                                  
	 
	 	 
	 

	 	                                                                                                                        
	 
	 	 
	 

	 	                                                                                                                        
	 
	 	 
	 

	 	                                                                                                                        

Signature Page to Registration Rights Agreement

 

 

Exhibit A

Certain Definitions

     “Business Day” means a day (other than a Saturday or a Sunday) on which banks are open
for business in London and Luxembourg.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules
and regulations thereunder, as the same are in effect from time to time.

     “Person” means any individual, firm, corporation, trust, company, government, state or
agency of a state or any joint venture, association or partnership (whether or not having separate
legal personality).

     “Purchaser Common Stock” means the common stock of the Purchaser, $0.001 par value per
share.

     “SEC” means the United States Securities and Exchange Commission.

     “Securities Act” means the Securities Act of 1933, as amended, and the rules and
regulations thereunder, as the same are in effect from time to time.

     “Registrable Shares” means the shares of Purchaser Common Stock being issued to the
Investors pursuant to the Purchase Agreement, together with any other securities of the Purchaser
issued or issuable as a result of or in connection with any stock dividend, stock split, or reverse
stock split, reclassification, merger, consolidation, or similar transaction in respect of such
shares; provided, however, that: Registrable Shares shall cease to be Registrable Shares when: (i)
a registration statement covering such Registrable Shares shall have become effective under the
Securities Act, and such Registrable Shares shall have been disposed of in accordance with the
Registration Statement; or (ii) one year after the date of this Agreement.

     “Working Hours” means 9.30 a.m. to 5.30 p.m. on a Business Day.

 

 

Exhibit B

Certificate of Subsequent Sale

	 	RE:	 	Sale of Shares of Common Stock of eBay Inc. (the “Purchaser”) pursuant to the
Prospectus dated                     , ___and Prospectus Supplement dated ___
(collectively, the “Prospectus”)

Dear Sir/Madam:

     The undersigned hereby certifies, in connection with the sale of shares of Common Stock of the
Purchaser included in the table of Selling Stockholders in the Prospectus, that the undersigned has
sold the shares pursuant to the Prospectus and in a manner described under the caption “Plan of
Distribution” in the Prospectus and that such sale complies with all securities laws applicable to
the undersigned, including, without limitation, the Prospectus delivery requirements of the
Securities Act of 1933, as amended.

Selling Stockholder (the beneficial owner):                                                                                 

Record Holder (e.g., if held in name of nominee):                                                                                 

Restricted Stock Certificate No.(s):                                                                                 

Number of Shares Sold:                                                                                 

Date of Sale:                                                                                 

     In the event that you receive a stock certificate(s) representing more shares of Common Stock
than have been sold by the undersigned, then you should return to the undersigned a newly issued
certificate for such excess shares in the name of the Record Holder.

	 	 	 	 	 	 	 	 	 
	 	 	 	 	Very truly yours,
	 
	 	 	 	 	 	 	 	 
	Dated:                                                             

	 	 	 	By:	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	Print Name:
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	Title:	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	cc:exv4w1

 

Exhibit 4.1

Warrant No. ________________

COMMON STOCK PURCHASE WARRANT

To Purchase __________ Shares of Common Stock of

SPECTRUM PHARMACEUTICALS, INC.

     THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received,
___(the “Holder”), is entitled to subscribe for and purchase from Spectrum
Pharmaceuticals, Inc., a Delaware corporation (the “Company”), upon the terms and subject
to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the “Initial Exercise Date”), and on or prior to the close of business on
September 15, 2011 (the “Expiration Date”) but not thereafter, up to ___shares (the
“Warrant Shares”) of Common Stock, par value $6.62 per share, of the Company (the
“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall
be equal to the Exercise Price, as defined in Section 2(b).

     Section 1. Definitions. Capitalized terms used and not otherwise
defined herein shall have the meanings set forth in that certain Securities Purchase
Agreement (the “Purchase Agreement”), dated September 14, 2005, among the Company
and the purchasers signatory thereto.

     Section 2. Exercise.

a) Exercise of Warrant. Exercise of the purchase rights represented by this
Warrant may be made at any time or times, in whole or in part, on or after the Initial Exercise Date until
5:00 P.M. (New York City time), on the Expiration Date by delivery to the Company of
a duly executed facsimile copy of the Notice of Exercise Form annexed hereto (or
such other office or agency of the Company as it may designate by notice in writing
to the registered Holder at the address of such Holder appearing on the books of the
Company); provided, however, within 5 Trading Days (a day on which
the Nasdaq Stock Market is open for ordinary trading) of the date said Notice of
Exercise is delivered to the Company, the Holder shall have surrendered this Warrant
to the Company and the Company shall have received payment of the aggregate Exercise
Price of the shares thereby purchased by wire transfer or cashier’s check drawn on a
United States bank.

b) Exercise Price. The exercise price of the Common Stock under this
Warrant shall be $6.62, subject to adjustment under Section 3 hereof (the
“Exercise Price”).

     c) Net Exchange.
 If at the time of exercise of this Warrant there is no effective registration statement permitting the sale
of the Warrant Shares by the Company to the Holder, then this Warrant may also be
exchanged at such time and from time to time, in whole or in part, for the number of Warrant Shares equal to the quotient
obtained by dividing [(A-B) (X)] by (A), where:

	 	(A)	 	 = the closing bid price on the Trading Day immediately
preceding the date of such election as reported by Bloomberg, L.P.;
	 
	 	(B)	 	 = the Exercise Price of this Warrant, as adjusted; and
	 
	 	(X)	 	 = the number of Warrant Shares issuable upon exercise of this
Warrant in accordance with the terms of this Warrant by means of a cash
exercise rather than a net exchange.

     d) Exercise Limitations.

     i. Holder’s Restrictions. The Holder shall not have the right
to exercise any portion of this Warrant to the extent that after giving
effect to such issuance after exercise, the Holder (together with the
Holder’s affiliates), as set forth on the applicable Notice of Exercise,
would beneficially own in excess of 9.99% of the number of shares of

 

 

the Common Stock outstanding immediately after giving effect to such
issuance (such limitation being referred to herein as the “Beneficial
Ownership Cap”). For purposes of the Beneficial Ownership Cap, the
number of shares of Common Stock beneficially owned by the Holder and its
affiliates shall include the number of shares of Common Stock issuable upon
exercise of this Warrant with respect to which the determination of such
sentence is being made, but shall exclude the number of shares of Common
Stock which would be issuable upon (A) exercise of the remaining,
nonexercised portion of this Warrant beneficially owned by the Holder or any
of its affiliates and (B) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including,
without limitation, any other Shares or Warrants) subject to a limitation on
conversion or exercise analogous to the Beneficial Ownership Cap
beneficially owned by the Holder or any of its affiliates. Except as set
forth in the preceding sentence, for purposes of this Section 2(c),
beneficial ownership shall be calculated in accordance with Section 13(d) of
the Exchange Act, it being acknowledged by Holder that the Company is not
representing to Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and Holder is solely responsible for any schedules
required to be filed in accordance therewith. To the extent that the
Beneficial Ownership Cap applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder) and of
which a portion of this Warrant is exercisable shall be in the sole
discretion of such Holder, and the submission of a Notice of Exercise shall
be deemed to be such Holder’s representation to the Company that its Warrant
is exercisable (in relation to other securities owned by such Holder) and of
which portion of this Warrant is exercisable, in each case subject to such
aggregate percentage limitation, and the Company shall have no obligation to
verify or confirm the accuracy of such determination. For purposes of this
Section 2(d), in determining the number of outstanding shares of Common
Stock, the Holder may rely on the number of outstanding shares of Common
Stock as reflected in (x) the Company’s most recent Form 10-Q or Form 10-K,
as the case may be, (y) a more recent public announcement by the Company or
(z) any other notice by the Company or the Company’s Transfer Agent setting
forth the number of shares of Common Stock outstanding. Upon the written or
oral request of the Holder, the Company shall within two Trading Days
confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of
Common Stock shall be determined after giving effect to the conversion or
exercise of securities of the Company, including this Warrant, by the Holder
or its affiliates since the date as of which such number of outstanding shares of Common Stock was reported.

     e) Mechanics of Exercise.

     i. Authorization of Warrant Shares. The Company covenants that
all Warrant Shares which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase
rights represented by this Warrant, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges in
respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).

     ii. Delivery of Certificates Upon Exercise. Certificates for shares purchased hereunder shall be transmitted by the transfer agent of the
Company to the Holder by crediting the account of the Holder’s prime broker
with the Depository Trust Company through its Deposit Withdrawal Agent
Commission (“DWAC”) system if the Company is a participant in such
system, and otherwise by physical delivery to the address specified by the
Holder in the Notice of Exercise within 3 Trading Days from the delivery to
the Company of the Notice of Exercise Form, surrender of this Warrant and
payment of the aggregate Exercise Price as set forth above (“Warrant
Share Delivery Date”). This Warrant shall be deemed to have been
exercised on the date the Exercise Price is received by the Company. The
Warrant Shares shall be deemed to have been issued, and Holder

 

 

or any other person so designated to be named therein shall be deemed
to have become a holder of record of such shares for all purposes, as of the
date the Warrant has been exercised by payment to the Company of the
Exercise Price and all taxes required to be paid by the Holder, if any,
pursuant to Section 2(e)(v) prior to the issuance of such shares, have been
paid.

     iii. Delivery of New Warrants Upon Exercise. If this Warrant
shall have been exercised in part, the Company shall, at the time of
delivery of the certificate or certificates representing Warrant Shares,
deliver to Holder a new Warrant evidencing the rights of Holder to purchase
the unpurchased Warrant Shares called for by this Warrant, which new Warrant
shall in all other respects be identical with this Warrant.

     iv. No Fractional Shares or Scrip. No fractional shares or
scrip representing fractional shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share which Holder would otherwise be
entitled to purchase upon such exercise, the Company shall pay a cash
adjustment in respect of such final fraction in an amount equal to such
fraction multiplied by the Exercise Price.

     v. Charges, Taxes and Expenses. Issuance of certificates for
Warrant Shares shall be made without charge to the Holder for any issue or
transfer tax or other incidental expense in respect of the issuance of such
certificate, all of which taxes and expenses shall be paid by the Company,
and such certificates shall be issued in the name of the Holder or in such
name or names as may be directed by the Holder; provided,
however, that in the event certificates for Warrant Shares are to be
issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form
attached hereto duly executed by the Holder; and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any
transfer tax incidental thereto.

     vi. Closing of Books. The Company will not close its
stockholder books or records in any manner which prevents the timely
exercise of this Warrant, pursuant to the terms hereof.

     Section 3. Certain Adjustments.

     a) Stock Dividends and Splits. If the Company, at any time while this Warrant
is outstanding: (A) pays a stock dividend or otherwise makes a distribution or distributions
on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of
doubt, shall not include any shares of
Common Stock issued by the Company pursuant to this Warrant), (B) subdivides outstanding shares of Common Stock into a larger number of shares, (C) combines (including by way of
reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or
(D) issues by reclassification of shares of the Common Stock any shares of capital stock of
the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if
any) outstanding before such event and of which the denominator shall be the number of shares of Common Stock outstanding after such event and the number of shares issuable upon
exercise of this Warrant shall be proportionately adjusted. Any adjustment made pursuant to
this Section 3(a) shall become effective immediately after the record date for the
determination of stockholders entitled to receive such dividend or distribution and shall
become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.

     b) Fundamental Transactions. If any capital reorganization, reclassification
of the capital stock of the Company, consolidation or merger of the Company with another
corporation in which the Company is not the survivor, or sale, transfer or other disposition
of all or substantially all of the Company’s assets to another corporation shall be
effected, then the Company shall use its best efforts to ensure that lawful and adequate
provision shall be made whereby each Holder shall thereafter continue to

 

 

have the right to purchase and receive upon the basis and upon the terms and conditions
herein specified and in lieu of the Warrant Shares issuable upon exercise of this Warrant,
such shares of stock, securities or assets as would have been issuable or payable with
respect to or in exchange for a number of Warrant Shares equal to the number of Warrant Shares issuable upon exercise of the Warrant, had such reorganization, reclassification,
consolidation, merger, sale, transfer or other disposition not taken place, and in any such
case appropriate provision shall be made with respect to the rights and interests of each
Holder to the end that the provisions hereof (including, without limitation, provision for
adjustment of the Exercise Price) shall thereafter be applicable, as nearly equivalent as
may be practicable in relation to any shares of stock, securities or assets thereafter
deliverable upon the exercise thereof. The Company shall not effect any such consolidation,
merger, sale, transfer or other disposition unless prior to or simultaneously with the
consummation thereof the successor corporation (if other than the Company) resulting from
such consolidation or merger, or the corporation purchasing or otherwise acquiring such
assets or other appropriate corporation or entity shall assume by written instrument,
reasonably deemed by both the Board of Directors of the Company and Holders representing at
least a majority of the Warrant Shares issuable upon exercise of all Warrants issued in the
same offering as this Warrant to be satisfactory in form and
substance, such affirmative assessment not to be unreasonably
withheld, the obligation to
deliver to the holder of the Warrant, at the last address of such holder appearing on the
books of the Company, such shares of stock, securities or assets as, in accordance with the
foregoing provisions, such holder may be entitled to purchase, and the other obligations of
the Company under this Warrant. The provisions of this section shall similarly apply to
successive reorganizations, reclassifications, consolidations, mergers, sales, transfers or
other dispositions. If the Company, in spite of using its best efforts, is unable to cause
this Warrant to continue in full force and effect until the Expiration Date in connection
with any capital reorganization, reclassification of the capital stock of the Company,
consolidation or merger of the Company with another corporation in which the Company is not
the survivor, or sale, transfer or other disposition of all or substantially all of the
Company’s assets to another corporation, then the Company shall pay the Holder an amount
calculated in accordance with the Black-Scholes Option Pricing formula set forth in the
appendix hereto.

     c) Calculations. All calculations under this Section 3 shall be made to the
nearest cent or the nearest 1/100th of a share, as the case may be. The number of shares of
Common Stock outstanding at any given time shall not include shares of Common Stock owned or
held by or for the account of the Company, and the description of any such shares of Common
Stock shall be considered on issue or sale of Common Stock. For purposes of this Section 3,
the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any)
issued and outstanding.

     d) Notice to Holders.

     i. Adjustment to Exercise Price. Whenever the Exercise Price is
adjusted pursuant to this Section 3, the Company shall promptly mail to each
Holder a notice setting forth the Exercise Price after such adjustment and
setting forth a brief statement of the facts requiring such adjustment.

     Notice to Allow Exercise by Holder. If (A) the Company shall
declare a dividend (or any other distribution) on the Common Stock; (B) the
Company shall declare a special nonrecurring cash dividend on or a
redemption of the Common Stock; (C) the Company shall authorize the granting
to all holders of the Common Stock rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights; (D) the
approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger
to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, of any compulsory share
exchange whereby the Common Stock is converted into other securities, cash
or property; (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company; then,
in each case, the Company shall cause to be mailed to the Holder at its last
addresses as it shall appear upon the Warrant Register of the Company, at
least twenty (20) calendar days prior to the applicable record or effective
date hereinafter

 

 

specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or
warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y)
the date on which such reclassification, consolidation, merger, sale,
transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for
securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided,
that the failure to mail such notice or any defect therein or in the mailing
thereof shall not affect the validity of the corporate action required to be
specified in such notice. The Holder is entitled to exercise this Warrant
during the 20-day period commencing the date of such notice to the effective
date of the event triggering such notice.

     Section 4. Transfer of Warrant.

a) Right of First Refusal. Should the Holder propose to sell or transfer
this Warrant to a non-affiliate of Holder in response to a bona fide offer to
purchase, the Holder shall promptly deliver a written notice to the Company. The
notice shall describe in reasonable detail the proposed sale or transfer, including,
without limitation, the number of Warrant Shares to be sold or transferred, the
consideration to be paid, the name and address of each prospective purchaser or
transferee, and any other material terms and conditions upon which such sale or
transfer is to be made, along with copies of all material proposed agreements
relating to such sale, including purchase agreements and other agreements or
documents requested by the Company. The Company shall have the option, exercisable
upon written notice to the Holder within two (2) business days after delivery of
the notice, to purchase some or all of the Warrant Shares on the same terms as the
proposed sale or transfer. Upon such purchase by the Company, this Warrant shall
promptly be cancelled and the Company shall issue to the Holder a new Warrant
evidencing the portion of this Warrant not purchased by the Company, if any. If the
Company does not exercise its option to purchase this warrant, the Holder may sell
or transfer this Warrant to the purchaser or transferee identified in the notice, on
the same terms as identified in the notice or otherwise.

b) Transferability. Subject to compliance with any applicable securities
laws and the conditions set forth in Section 4(a) hereof, this Warrant and all rights hereunder are
transferable, in whole or in part, upon surrender of this Warrant at the principal
office of the Company, together with a written assignment of this Warrant
substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company
shall execute and deliver a new Warrant or Warrants in the name of the assignee or
assignees and in the denomination or denominations specified in such instrument of
assignment, and shall issue to the assignor a new Warrant evidencing the portion of
this Warrant not so assigned, and this Warrant shall promptly be cancelled. A
Warrant, if properly assigned, may be exercised by a new holder for the purchase of
Warrant Shares without having a new Warrant issued.

c) New Warrants. This Warrant may be divided or combined with other Warrants
upon presentation hereof at the aforesaid office of the Company, together with a
written notice specifying the names and denominations in which new Warrants are to
be issued, signed by the Holder or its agent or attorney. Subject to compliance
with Sections 4(a) and (b), as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice.

 

 

d) Warrant Register. The Company shall register this Warrant, upon records
to be maintained by the Company for that purpose (the “Warrant Register”),
in the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the
purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.

Section 5. Miscellaneous.

a) Title to Warrant. Prior to the Expiration Date and subject to compliance
with applicable laws and Section 4 of this Warrant, this Warrant and all rights
hereunder are transferable, in whole or in part, at the office or agency of the
Company by the Holder in person or by duly authorized attorney, upon surrender of
this Warrant together with the Assignment Form annexed hereto properly endorsed.
The transferee shall sign an investment letter in form and substance reasonably
satisfactory to the Company.

b) No Rights as Shareholder Until Exercise. This Warrant does not entitle
the Holder to any voting rights or other rights as a shareholder of the Company
prior to the exercise hereof. Upon the surrender of this Warrant and the payment of
the aggregate Exercise Price (or by means of a cashless exercise), the Warrant Shares so purchased shall be and be deemed to be issued to such Holder as the record
owner of such shares as of the close of business on the later of the date of such
surrender or payment.

c) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants
that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of
indemnity or security reasonably satisfactory to it (which, in the case of the
Warrant, shall not include the posting of any bond), and upon surrender and
cancellation of such Warrant or stock certificate, if mutilated, the Company will
make and deliver a new Warrant or stock certificate of like tenor and dated as of
such cancellation, in lieu of such Warrant or stock certificate.

d) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein shall
be a Saturday, Sunday or a legal holiday, then such action may be taken or such
right may be exercised on the next succeeding day not a Saturday, Sunday or legal
holiday.

e) Authorized Shares.

The Company covenants that during the period the Warrant is outstanding, it
will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any
purchase rights under this Warrant. The Company further covenants that its issuance
of this Warrant shall constitute full authority to its officers who are charged with
the duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights under
this Warrant. The Company will take all such reasonable action as may be necessary
to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the trading
markets upon which the Common Stock may be listed.

Except and to the extent as waived or consented to by the Holder, the Company
shall not by any action, including, without limitation, amending its certificate of
incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such
terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the

 

 

foregoing, the Company will (a) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to
such increase in par value, (b) take all such action as may be necessary or
appropriate in order that the Company may validly and legally issue fully paid and
nonassessable Warrant Shares upon the exercise of this Warrant, and (c) use
commercially reasonable efforts to obtain all such authorizations, exemptions or
consents from any public regulatory body having jurisdiction thereof as may be
necessary to enable the Company to perform its obligations under this Warrant.

f) Jurisdiction. All questions concerning the construction, validity,
enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.

g) Restrictions. The Holder acknowledges that the Warrant Shares acquired
upon the exercise of this Warrant, if not registered, will have restrictions upon
resale imposed by state and federal securities laws.

h) Nonwaiver and Expenses. No course of dealing or any delay or failure to
exercise any right hereunder on the part of Holder shall operate as a waiver of such
right or otherwise prejudice Holder’s rights, powers or remedies, notwithstanding
the fact that all rights hereunder terminate on the Expiration Date. If the Company
willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to Holder such
amounts as shall be sufficient to cover any costs and expenses including, but not
limited to, reasonable attorneys’ fees, including those of appellate proceedings,
incurred by Holder in collecting any amounts due pursuant hereto or in otherwise
enforcing any of its rights, powers or remedies hereunder.

i) Notices. Any notice, request or other document required or permitted to
be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Purchase Agreement.

j) Limitation of Liability. No provision hereof, in the absence of any
affirmative action by Holder to exercise this Warrant or purchase Warrant Shares,
and no enumeration herein of the rights or privileges of Holder, shall give rise to
any liability of Holder for the purchase price of any Common Stock or as a
stockholder of the Company, whether such liability is asserted by the Company or by
creditors of the Company.

k) Remedies. Holder, in addition to being entitled to exercise all rights
granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary
damages would not be adequate compensation for any loss incurred by reason of a
breach by it of the provisions of this Warrant and hereby agrees to waive the
defense in any action for specific performance that a remedy at law would be
adequate.

l) Successors and Assigns. Subject to applicable securities laws, this
Warrant and the rights and obligations evidenced hereby shall inure to the benefit
of and be binding upon the successors of the Company and the successors and
permitted assigns of Holder. The provisions of this Warrant are intended to be for
the benefit of all Holders from time to time of this Warrant and shall be
enforceable by any such Holder or holder of Warrant Shares but nothing in this
Warrant shall be construed to give any person or Company or other entity, other than
the Company and the Holder and their respective successor and assigns, any legal or
equitable right, remedy or cause under this Warrant.

m) Amendment. This Warrant may be modified or amended or the provisions
hereof waived with the written consent of the Company and the Holder.

 

 

n) Severability. Wherever possible, each provision of this Warrant shall be
interpreted in such manner as to be effective and valid under applicable law, but if
any provision of this Warrant shall be prohibited by or invalid under applicable
law, such provision shall be ineffective to the extent of such prohibition or
invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

o) Headings. The headings used in this Warrant are for the convenience of
reference only and shall not, for any purpose, be deemed a part of this Warrant.

********************

 

 

APPENDIX

Black Scholes Option Pricing formula to be used when calculating the amount per Warrant Share
shall be: C = StN(d1) — Ke-r(T-t)N(d2), where

C = warrant value

S = price of Company stock as determined by reference to the closing price on the securities
exchange or Nasdaq National Market over the 20-day period ending three trading days prior to the
closing of the capital reorganization, reclassification of the capital stock of the Company,
consolidation or merger of the Company with another corporation in which the Company is not the
survivor, or sale, transfer or other disposition of all or substantially all of the Company’s
assets to another corporation described in Section 3(b) if the Company’s stock is then traded on
such exchange or system, or the average of the closing bid or sale prices (whichever is applicable)
in the over-the-counter market over the 20-day period ending three trading days prior to the
closing of the transaction if the Company’s stock is then actively traded in the over-the-counter
market, or the then most recently completed financing if the Company’s stock is not then traded on
a securities exchange or system or in the over-the-counter market.

T =
9/15/2011

t = date of issue of warrant

T-t = time until warrant expiration = ___days or ___months

N = volatility = average of the daily price changes on the securities exchange or Nasdaq National
Market over the 20-day period ending three trading days prior to the public announcement of the
capital reorganization, reclassification of the capital stock of the Company, consolidation or
merger of the Company with another corporation in which the Company is not the survivor, or sale,
transfer or other disposition of all or substantially all of the Company’s assets to another
corporation described in Section 3(b) if the Company’s stock is then traded on such exchange or
system, or the average of the daily change in the closing bid or sale prices (whichever is
applicable) in the over-the-counter market over the 20-day period ending three trading days prior
to the public announcement of the transaction if the Company’s stock is then actively traded in the
over-the-counter market, or 0.6 if the Company’s stock is not then traded on a securities exchange
or system or in the over-the-counter market.

d1
= (ln(S/K) +
(r-l+N+N/2)(T-t))
÷ (NÖ(T-t))

ln = natural logarithm

ë = dividend rate for the most recent 12-month period at the time of closing of the capital
reorganization, reclassification of the capital stock of the Company, consolidation or merger of
the Company with another corporation in which the Company is not the survivor, or sale, transfer or
other disposition of all or substantially all of the Company’s assets to another corporation.

K = $6.62

r = the 90-day Treasury Bill rate from the most recent auction reported on the website:
www.publicdebt.treas.gov

d2 = d1- NÖ(T-t)/365

 

 

     IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its
officer thereunto duly authorized.

Dated:
September 15, 2005

	 	 	 	 	 	 	 
	 	 	 	 	Spectrum Pharmaceuticals, Inc.
	 
	 	 	 	 	 	 
	 

	 	 	 	By:	 	 
	 

	 	 	 	 	 	 

	 

	 	 	 	Name:	 	 
	 

	 	 	 	 	 	 

	 

	 	 	 	Title:	 	 
	 

	 	 	 	 	 	 

	 
	 	 	 	 	 	 
	Attest:	 	 	 	 
	 
	 	 	 	 	 	 
	By:
	 	 	 	 	 	 
	 

	 	 
	 	 	 	 
	Name:
	 	 	 	 	 	 
	 

	 	 
	 	 	 	 
	Title:
	 	 	 	 	 	 
	 

	 	 
	 	 	 	 

 

 

NOTICE OF EXERCISE

TO: SPECTRUM PHARMACEUTICALS, INC.

     (1) The undersigned hereby elects:

o to purchase ___Warrant Shares, Warrant Number
___, of the Company pursuant to the terms of the attached
Warrant and tenders herewith payment of the exercise price in full in lawful
money of the United States, together with all applicable transfer taxes, if
any.

o to exchange this Warrant for the number of Warrant Shares determined
pursuant to the net exchange procedure set forth in subsection 2(c).

     (2) Please issue said Warrant Shares in the name of the undersigned or in such other name as
is specified below:

 

The Warrant Shares shall be delivered to the following address:

 

 

 

OR

	 	 	 	 	 	 	 
	 	 	DWAC the shares to:	 	 
	 
	 	 	 	 	 	 
	 

	 	DTC #	 	 	 	 
	 

	 	 	 	 
	 	 
	 

	 	Account #	 	 	 	 
	 

	 	 	 	 
	 	 
	 

	 	Reference #	 	 	 	 
	 

	 	 	 	 
	 	 

SIGNATURE OF HOLDER

	 	 	 
	 

	 	 
	Name of Investing Entity
	 	 
	 
	 	 
	 

	 	 

	Signature of Authorized Signatory of Investing Entity

	 	Date
	 
	 	 
	 

	 	 

	Name of Authorized Signatory

	 	Title of Authorized Signature

 

 

ASSIGNMENT FORM

(To assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

	 	 	 	 	 
	Warrant Number:

	 	 	 	 
	 

	 	 
	 	 
	Warrant Shares:
	 	 	 	 
	 

	 	 
	 	 

     FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby
assigned to:

	 	 	 
	 

	 	whose address is
	 

	 	 
	 
	 	 
	 

	 	 . 
	 

	 	 

Dated:                ,      

	 	 	 	 	 
	 

	 	Holder’s Signature:	 	 
	 

	 	 	 	 

	 

	 	Holder’s Address:	 	 
	 

	 	 	 	 

	 
	 	 	 	 
	 

	 	 	 	 

	 	 	 	 	 
	Signature Guaranteed:

	 	 	 	 
	 

	 	 
	 	 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the
face of the Warrant, without alteration or enlargement or any change whatsoever, and must be
guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or
other representative capacity should file proper evidence of authority to assign the foregoing
Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]